Marco Holdener

INACTIVE XING-PROFILE Please refer to my LinkedIn profile for up-to-date information and activity. Thanks a lot. Gerne verweise ich Sie auf mein LinkedIn-Profil für aktuelle Details und Aktivitäten. Besten Dank.

Achievements: • Led the financial carve out enabling the valuation of the entire Diabetes Care business on a standalone basis (reverse due diligence) as prerequisite for the bidding, sale and separation process • Business partner for senior leaders, successfully driving audit and sponsor reviews

• Finance lead for all internal Consumer EMEA plants • Key business partner to the EMEA supply chain leadership team and global make finance Achievements: • Ensured that the relevant financial insights were available for regional VP and plant leadership teams to make most beneficial decisions • Successful led and developed finance professionals across 10 EMEA manufacturing sites during a comprehensive organizational transformation process

Achievements: • Enabled business growth into new markets by identifying and implementing treasury solutions • Ensured business continuation in Russia during finance crisis • Secured currency transfers during finance crisis in Egypt • Overall lead of Greece business contingency plan in anticipation of a potential Grexit • Successful transformation of regional treasury team to a valued, strategic business partner

Achievements: • Finance lead and key project team member successfully driving and completing various initiatives (ex. consolidating individual country warehouses into one EMEA wide distribution network driving cost savings by efficiency increases and overall inventory reductions / transfer of market rights for a large bioproduct from a competitor / various major tax projects)

• Finance lead with P&L and BS responsibility for business unit sourcing biological products (substantial sales, inventory and FX exposure) • Key business partner for US based finance team and supply chain management, R&D, corporate tax, internal and external audit • Finance partner defining product flows in preparation of the launch of new biological products in close cooperation with all involved global and cross-functional teams

• Financial ownership of major pharmaceutical blockbuster products (including forecast and close activities, scorecards, Subpart F tax calculations, external royalty audits) • Partnering with suppliers and subcontractors in manufacturing and inventory related areas (productions loss, yield analysis, manufacturing fees, royalty & milestone payments) • Compliance lead and contact for internal and external auditors

• Responsibility for financial analysis and reporting of local plant including month end close activities, financial forecasts and preparation of regional management reviews